Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,471,000 | 4,167,000 | 3,141,000 | 3,205,000 | 2,850,000 |
| Depreciation Amortization | 685,000 | 678,000 | 625,000 | 591,000 | 519,000 |
| Accounts receivable | -507,000 | N/A | N/A | N/A | N/A |
| Other Working Capital | -509,000 | -375,000 | 0 | -1,353,000 | -728,000 |
| Other Operating Activity | 512,000 | 0 | 354,000 | 33,000 | 0 |
| Operating Cash Flow | $4,652,000 | $4,470,000 | $4,120,000 | $2,476,000 | $2,641,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -589,000 | -709,000 | -788,000 | -767,000 | -601,000 |
| Net Acquisitions | 652,000 | -132,000 | 324,000 | 116,000 | -103,000 |
| Sale Of Investment | 45,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -82,000 | 82,000 | 118,000 | 119,000 | -13,000 |
| Investing Cash Flow | $16,000 | $-759,000 | $-346,000 | $-532,000 | $-717,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -247,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 17,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -11,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 352,000 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -2,338,000 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,930,000 | -1,707,000 | -1,551,000 | -1,515,000 | -1,507,000 |
| Other Financing Activity | 0 | -1,491,000 | -1,429,000 | -636,000 | -378,000 |
| Financing Cash Flow | $-4,157,000 | $-3,198,000 | $-2,980,000 | $-2,151,000 | $-1,885,000 |
| Exchange Rate Effect | -49,000 | -37,000 | -6,000 | -18,000 | -3,000 |
| Beginning Cash Position | 2,720,000 | 2,244,000 | 1,456,000 | 1,681,000 | 1,645,000 |
| End Cash Position | 3,182,000 | 2,720,000 | 2,244,000 | 1,456,000 | 1,681,000 |
| Net Cash Flow | $462,000 | $476,000 | $788,000 | $-225,000 | $36,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,652,000 | 4,470,000 | 4,120,000 | 2,476,000 | 2,641,000 |
| Capital Expenditure | -589,000 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 4,063,000 | 4,470,000 | 4,120,000 | 2,476,000 | 2,641,000 |